How much is Hyku Biosciences worth in 2026?

Hyku Biosciences has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Hyku Biosciences raised?

Hyku Biosciences has raised N/A in total funding across 1 funding rounds.

Hyku Biosciences

Drug Discovery

Hyku Biosciences valuation and funding history | Last updated: November 12, 2024 | 1 funding rounds

Current Valuation

N/A

As of November 12, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$64.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 12, 2024	Seed Round	$64.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Hyku Biosciences is currently valued at N/A as of November 12, 2024.

Track Hyku Biosciences Valuation Updates

Get notified when Hyku Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Hyku Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Hyku Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Hyku Biosciences Worth in 2026?

Hyku Biosciences is a leading private company in the Drug Discovery sector. Track Hyku Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Hyku Biosciences Valuation is Determined

Private company valuations like Hyku Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.